Cardizem la and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Cardizem la (diltiazem hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Weakness when taking Cardizem la. It is created by eHealthMe based on reports of 882 people who have side effects when taking Cardizem la from the FDA, and is updated regularly.

What is Cardizem la?

Cardizem la has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 941 Cardizem la users. Check the latest studies of Cardizem la.

What is Weakness?

Weakness is found to be associated with 3,640 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 20, 2026

882 people reported to have side effects when taking Cardizem la.
Among them, 38 people (4.31%) have Weakness.

Among these 38 people:

How long have people been on Cardizem la when they have Weakness? *

What is the gender of people who have Weakness when taking Cardizem la? *

female: 68.42 %
male: 31.58 %

What is the age of people who have Weakness when taking Cardizem la? *

What are other drugs people take besides Cardizem la? *

What are other side effects people have besides Weakness? *

Nausea (feeling of having an urge to vomit): 15 people, 39.47%
Nausea And Vomiting: 12 people, 31.58%
Dyspnea (difficult or laboured breathing): 11 people, 28.95%
Diarrhea: 10 people, 26.32%
Abdominal Pain: 9 people, 23.68%
Weight Decreased: 8 people, 21.05%
Headache (pain in head): 8 people, 21.05%
Fatigue (feeling of tiredness): 8 people, 21.05%
Pain: 7 people, 18.42%
Pain In Extremity: 7 people, 18.42%

What are the existing conditions these people have? *

High Blood Cholesterol: 4 people, 10.53%
Renal Cell Carcinoma (a kidney cancer): 3 people, 7.89%
Pain: 3 people, 7.89%
Cardiac Failure Congestive: 2 people, 5.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.26%
Back Pain: 2 people, 5.26%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 5.26%
Ovarian Cancer (cancer of ovary): 2 people, 5.26%
Hyperkalemia (damage to or disease of the kidney): 2 people, 5.26%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Cardizem la and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cardizem la:

Cardizem la (941 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Cardizem la:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,640 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,612 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diltiazem hydrochloride (the active ingredients of Cardizem la) and Cardizem la (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.